1. Chebanov DK. DIAGNOSIS AND PROGNOSIS OF THE COURSE OF BREAST CANCER BASED ON THE PROFILE OF THE EXPRESSION OF MICRORNA OF TUMOR EXOSOMES / DK Tchebanov, IN Mikhailova, AA Abramov, NS Vorobyova // Oncogynecology – 2016 — 2 — 4-12.

2. Chebanov DK. Research of exosomal microRNAs in the blood plasma of patients with melanoma, including being in stable remission / DK Chebanov, AA Abramov, IN Mikhailova // Successes of Molecular Oncology – 2016 – 4(3) – 45-46.

3. Chebanov DK. Studying of exosomal miRNAs in blood plasma of patients with melanoma, including being in stable remission / DK Chebanov, AA Abramov, IN Mikhailova // Malignant Tumors – 2016 – 4(21) – 339.

4. Chebanov DK. Exosomal microRNA research in the blood plasma of patients with melanoma, including being in stable remission / DK Chebanov, AA Abramov, IN Mikhailova // Poster on The XX Russian Cancer Congress — 2016.

5. Chebanov DK. Studying of exosomal miRNAs in blood plasma of patients with melanoma, including being in stable remission / DK Chebanov, AA Abramov, IN Mikhailova // Thesis at the II All-Russian Conference on Molecular Oncology – 2016.

6. Chebanov DK, Abramov AA, «BIOINFORMATICS ALGORITHM FOR CALCULATING OF PATIENT'S RISK OF CARDIOVASCULAR DISEASE BASED ON GENOTYPIC AND PHENOTYPIC INDICATORS», Patent pending No 2016143134 — 2016

7. COMBINED METHOD OF ULTRASOUND THERAPY OF ONCOLOGICAL DISEASES
Nikolaev A.L., Gopin A.V., Bozhevol'Nov V.E., Treshalina H.M., Andronova N.V., Melikhov I.V., Filonenko D.V., Mazina S.E., Gerasimova G.K., Bokhyan B.Yu., Khorosheva E.V., Mikhailova I.N., Demidov L.V., Kogan B.Ya., Kaliya O.L.
Russian Journal of General Chemistry. 2015. Т. 85. № 1. С. 303-320.

8. INCREASED AUTOIMMUNE RESPONSES AGAINST AUTO-EPITOPES MODIFIED BY OXIDATIVE AND NITROSATIVE DAMAGE IN DEPRESSION: IMPLICATIONS FOR THE PATHWAYS TO CHRONIC DEPRESSION AND NEUROPROGRESSION
Maes M., Kubera M., Mihaylova I., Geffard M., Galecki P., Leunis J.C., Berk M.
Journal of Affective Disorders. 2013. Т. 149. С. 23.

9. LOOKING INTO THE FUTURE OF IMMUNOTHERAPY OR HOW TO FIND CINDERELLA?
Shubina I.Z., Titov K.S., Mikhailova I.N., Kiselevsky M.V.
International Journal of Cancer Prevention. 2014. Т. 6. № 3-4. С. 413-424.

10. ACTIVATION OF CELL-MEDIATED IMMUNITY IN DEPRESSION: ASSOCIATION WITH INFLAMMATION, MELANCHOLIA, CLINICAL STAGING AND THE FATIGUE AND SOMATIC SYMPTOM CLUSTER OF DEPRESSION
Maes M., Mihaylova I., Kubera M., Ringel K.
Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2012. Т. 36. С. 169.

11. IGM-MEDIATED AUTOIMMUNE RESPONSES DIRECTED AGAINST ANCHORAGE EPITOPES ARE GREATER IN MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME (ME/CFS) THAN IN MAJOR DEPRESSION
Maes M., Mihaylova I., Kubera M., Leunis J.C., Twisk F.N., Geffard M.
Metabolic Brain Disease. 2012. Т. 27. № 4. С. 415.

12. ADJUVANT DENDRITIC CELL (DC)-BASED VACCINE THERAPY OF MELANOMA PATIENTS.
Petenko N.N., Mikhaylova I.N., Chkadua G.Z.
Journal of Clinical Oncology. 2012. Т. 30. № S. С. 2524.

13. IGM-MEDIATED AUTOIMMUNE RESPONSES DIRECTED AGAINST MULTIPLE NEOEPITOPES IN DEPRESSION: NEW PATHWAYS THAT UNDERPIN THE INFLAMMATORY AND NEUROPROGRESSIVE PATHOPHYSIOLOGY
Maes M., Mihaylova I., Kubera M., Leunis J.C., Geffard M.
Journal of Affective Disorders. 2011. Т. 135. С. 414.

14. INCREASED PLASMA PEROXIDES AND SERUM OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODIES IN MAJOR DEPRESSION: MARKERS THAT FURTHER EXPLAIN THE HIGHER INCIDENCE OF NEURODEGENERATION AND CORONARY ARTERY DISEASE
Maes M., Mihaylova I., Kubera M., Uytterhoeven M., Vrydags N., Bosmans E.
Journal of Affective Disorders. 2010. Т. 125. С. 287.

15. USE OF RECOMBINANT INTERLEUKIN-2 FOR INTRAPLEURAL THERAPY OF TUMOR-ASSOCIATED PLEURISY
Titov K.S., Kiselevskii M.V., Demidov L.V., Mikhailova I.N., Shubina I.Z., Rodionova L.M., Sinel'Nikov I.E., Topol' K.Y., Gritsai A.N.
Bulletin of Experimental Biology and Medicine. 2009. Т. 148. № 5. С. 794-796.

16. INCREASED 8-HYDROXY-DEOXYGUANOSINE, A MARKER OF OXIDATIVE DAMAGE TO DNA, IN MAJOR DEPRESSION AND MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME
Maes M., Mihaylova I., Kubera M., Uytterhoeven M., Vrydags N., Bosmans E.
Neuroendocrinology Letters. 2009. Т. 30. С. 715.

17. AN IGM-MEDIATED IMMUNE RESPONSE DIRECTED AGAINST NITRO-BOVINE SERUM ALBUMIN (NITRO-BSA) IN CHRONIC FATIGUE SYNDROME (CFS) AND MAJOR DEPRESSION: EVIDENCE THAT NITROSATIVE STRESS IS ANOTHER FACTOR UNDERPINNING THE COMORBIDITY BETWEEN MAJOR DEPRESSION AND CFS
Maes M., Mihaylova I., Kubera M., Leunis J.C.
Neuroendocrinology Letters. 2008. Т. 29. № 3. С. 313.

18. DECREASED EXPRESSION OF CD69 IN CHRONIC FATIGUE SYNDROME IN RELATION TO INFLAMMATORY MARKERS: EVIDENCE FOR A SEVERE DISORDER IN THE EARLY ACTIVATION OF T LYMPHOCYTES AND NATURAL KILLER CELLS
Mihaylova I., Deruyter M., Rummens J.L., Bosnians E., Maes M.
Neuroendocrinology Letters. 2007. Т. 28. № 4.

19. INCREASED SERUM IGM ANTIBODIES DIRECTED AGAINST PHOSPHATIDYL INOSITOL (PI) IN CHRONIC FATIGUE SYNDROME (CFS) AND MAJOR DEPRESSION: EVIDENCE THAT AN IGM-MEDIATED IMMUNE RESPONSE AGAINST PI IS ONE FACTOR UNDERPINNING THE COMORBIDITY BETWEEN BOTH CFS AND DEPRESSION
Maes M., Mihaylova I., Leunis J.C.
Neuroendocrinology Letters. 2007. Т. 28. № 6. С. 861.

20. LOWER SERUM ZINC IN CHRONIC FATIGUE SYNDROME (CFS): RELATIONSHIPS TO IMMUNE DYSFUNCTIONS AND RELEVANCE FOR THE OXIDATIVE STRESS STATUS IN CFS
Maes M., Mihaylova I., De Ruyter M.
Journal of Affective Disorders. 2006. Т. 90. № 2-3. С. 141.

21. CHRONIC FATIGUE SYNDROME IS ACCOMPANIED BY AN IGM-RELATED IMMUNE RESPONSE DIRECTED AGAINST NEOPITOPES FORMED BY OXIDATIVE OR NITROSATIVE DAMAGE TO LIPIDS AND PROTEINS
Maes M., Mihaylova I., Leunis J.-C.
Neuroendocrinology Letters. 2006. Т. 27. № 5. С. 615.

22. DECREASED DEHYDROEPIANDROSTERONE SULFATE BUT NORMAL INSULIN-LIKE GROWTH FACTOR IN CHRONIC FATIGUE SYNDROME (CFS): RELEVANCE FOR THE INFLAMMATORY RESPONSE IN CFS
Maes M., Mihaylova I., De Ruyter M.
Neuroendocrinology Letters. 2005. Т. 26. № 5. С. 487.

23. IN CHRONIC FATIGUE SYNDROME, THE DECREASED LEVELS OF OMEGA-3 POLY-UNSATURATED FATTY ACIDS ARE RELATED TO LOWERED SERUM ZINC AND DEFECTS IN T CELL ACTIVATION
Maes M., Mihaylova I., Leunis J.C.
Neuroendocrinology Letters. 2005. Т. 26. № 6. С. 745.

24. FUNCTIONAL CHARACTERISTICS OF MATURE NEUTROPHILS OF PERIPHERAL BLOOD IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
Blindar V.N., Zubrikhina G.N., Mikhailova I.N., Zakharova E.S., Zabotina T.N., Turkina A.G., Khoroshko N.D., Votyakova O.M., Volkova M.A., Baryshnikov A.Yu.
Гематология и трансфузиология. 2002. Т. 47. № 2. С. 13-16.

25. EXPRESSION OF ANTIGEN CD95(FAS/APO-1) MEDIATING APOPTOSIS IN HEMOBLASTOSES USING MONOCLONAL ANTIBODIES ICO-160
Polosukhina E.R., Baryshnikov A.Yu., Shishkin Yu.V., Zabotina T.N., Logacheva N.P., Tupitsyn N.N., Volkova M.A., Turkina A.G., Tsvetaeva N.V., Golenkov A.K., Shirin A.D., Kataeva E.V., Trifonova E.V., Mitina T.A., Mikhailova I.N., Lysyuk E.Yu., Mayakova S.A., Kadagidze Z.G.
Гематология и трансфузиология. 2000. Т. 45. № 4. С. 3-6.

26. THE TREATMENT OF PH-POSITIVE CHRONIC MYELOID LEUKEMIA WITH THE IFN-α DRUGS (INTRON-A, SHERING-PLOUGH; REAFERON, RUSSIA) IN COMBINATION WITH CHEMOTHERAPY
Khoroshko N.D., Turkina A.G., Zhuravlev V.S., Sokolova M.A., Mikhailova I.N., Zakharova A.V., Domracheva E.V., Semenova E.A.
Гематология и трансфузиология. 1996. Т. 41. № 3. С. 26-32.

27. WHY FISH OILS MAY NOT ALWAYS BE ADEQUATE TREATMENTS FOR DEPRESSION OR OTHER INFLAMMATORY ILLNESSES: DOCOSAHEXAENOIC ACID, AN OMEGA-3 POLYUNSATURATED FATTY ACID, INDUCES A TH-1-LIKE IMMUNE RESPONSE
Maes M., Mihaylova I., Kubera M., Bosmans E.
Neuroendocrinology Letters. 2007. Т. 28. С. 875.